These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 26476747)
1. Expression of adhesion proteins (E-cadherin and β-catenin) and cell proliferation (Ki-67) at the invasive tumor front in conventional oral squamous cell and basaloid squamous cell carcinomas. Pereira CH; Morais MO; Martins AF; Soares MQ; Alencar Rde C; Batista AC; Leles CR; Mendonça EF Arch Oral Biol; 2016 Jan; 61():8-15. PubMed ID: 26476747 [TBL] [Abstract][Full Text] [Related]
2. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables. Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043 [TBL] [Abstract][Full Text] [Related]
3. E-cadherin, β-catenin, and α2β1 and α3β1 integrin expression in primary oral squamous cell carcinoma and its regional metastasis. Soares MQ; Mendonça JA; Morais MO; Leles CR; Batista AC; Mendonça EF Histol Histopathol; 2015 Oct; 30(10):1213-22. PubMed ID: 25857731 [TBL] [Abstract][Full Text] [Related]
4. Effect of WNT-1 on beta-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma. Zhang WM; Lo Muzio L; Rubini C; Yan G Oncol Rep; 2005 Jun; 13(6):1095-9. PubMed ID: 15870927 [TBL] [Abstract][Full Text] [Related]
5. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267 [TBL] [Abstract][Full Text] [Related]
6. Beta- and gamma-catenin expression in oral squamous cell carcinomas. Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318 [TBL] [Abstract][Full Text] [Related]
7. [Expression of E-cadherin, N-cadherin, β-catenin and their clinical significance in laryngeal carcinoma]. Song PP; Qian XY; Zhou H; Shen XH; Liu DD; Feng AN; Gao X Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):440-5. PubMed ID: 27345880 [TBL] [Abstract][Full Text] [Related]
8. A clinicopathologic study on basaloid squamous cell carcinoma in the oral and maxillofacial region. Yu GY; Gao Y; Peng X; Chen Y; Zhao FY; Wu MJ Int J Oral Maxillofac Surg; 2008 Nov; 37(11):1003-8. PubMed ID: 18632253 [TBL] [Abstract][Full Text] [Related]
9. Decreased E-cadherin but not beta-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas. Kurtz KA; Hoffman HT; Zimmerman MB; Robinson RA Otolaryngol Head Neck Surg; 2006 Jan; 134(1):142-6. PubMed ID: 16399195 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx. Salerno G; Di Vizio D; Staibano S; Mottola G; Quaremba G; Mascolo M; Galli V; De Rosa G; Insabato L BMC Cancer; 2006 Jun; 6():146. PubMed ID: 16740156 [TBL] [Abstract][Full Text] [Related]
11. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas. Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700 [TBL] [Abstract][Full Text] [Related]
12. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator. Lam KY; Law S; Luk JM; Wong J J Pathol; 2001 Nov; 195(4):435-42. PubMed ID: 11745675 [TBL] [Abstract][Full Text] [Related]
13. Basaloid squamous cell carcinoma of the oral cavity: an analysis of 92 cases. Fritsch VA; Gerry DR; Lentsch EJ Laryngoscope; 2014 Jul; 124(7):1573-8. PubMed ID: 23946211 [TBL] [Abstract][Full Text] [Related]
14. Expression of Ki-67 and Βeta-Catenin in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma in Oral Mucosal Biopsies : An Immunohistochemical Study. Ahmad B; Asif M; Ali A; Jamal S; Khan MZ; Khadim MT Asian Pac J Cancer Prev; 2020 Jan; 21(1):157-161. PubMed ID: 31983178 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of basaloid squamous cell carcinoma, adenoid cystic and mucoepidermoid carcinoma in the upper aerodigestive tract. Tsubochi H; Suzuki T; Suzuki S; Ohashi Y; Ishibashi S; Moriya T; Fujimura S; Sasano H Anticancer Res; 2000; 20(2B):1205-11. PubMed ID: 10810423 [TBL] [Abstract][Full Text] [Related]
16. The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation. Wang X; Zhang J; Fan M; Zhou Q; Deng H; Aisharif MJ; Chen X Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Apr; 107(4):547-54. PubMed ID: 19327640 [TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers? Hanemann JA; Oliveira DT; Nonogaki S; Nishimoto IN; de Carli ML; Landman G; Kowalski LP BMC Cancer; 2014 Jun; 14():395. PubMed ID: 24893577 [TBL] [Abstract][Full Text] [Related]
18. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis. Mahomed F; Altini M; Meer S Oral Dis; 2007 Jul; 13(4):386-92. PubMed ID: 17577324 [TBL] [Abstract][Full Text] [Related]
19. Implications of Differential Expression of β-Catenin in Oral Carcinoma. Moles MA; Montoya JA; Salvago MD; Ávila IR; Campillo JJ; Bravo M Anticancer Res; 2016 Apr; 36(4):1599-604. PubMed ID: 27069136 [TBL] [Abstract][Full Text] [Related]
20. Altered expression of E-cadherin and β-catenin in malignant transformation of sinonasal inverted papillomas. Koo BS; Jung BJ; Kim SG; Liang ZL; Yeong MK; Rha KS Rhinology; 2011 Oct; 49(4):479-85. PubMed ID: 21991576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]